When Iron Won’t Budge: The Ferritin, Hepcidin and Microbiome Connection
You’re taking iron. You’ve improved your diet. You’ve been consistent. Yet your ferritin barely moves.
You’re taking iron. You’ve improved your diet. You’ve been consistent. Yet your ferritin barely moves.
You’re taking iron. You’ve improved your diet. You’ve been consistent.
Yet your ferritin barely moves.
At that point, I become interested in a different question:
What if the problem isn’t how much iron is going in — but what your body is doing with it?
One of the places we need to look is the gut.
Hepcidin is a hormone produced primarily by the liver and one of the body’s main regulators of iron.
When hepcidin rises, it reduces intestinal iron absorption and makes it harder for stored iron to be released back into circulation.
Think of it as closing the iron gates.
And one of the strongest signals that increases hepcidin is inflammation, particularly inflammatory signalling involving IL-6.
This is important because inflammation doesn’t have to mean a dramatic infection or obvious inflammatory disease. Chronic inflammatory activity — including inflammation within the gastrointestinal tract — may influence the way the body handles iron.
So you can keep supplying iron, but if the biological environment is working against its absorption and availability, the response may not be what you expect.
Our gut microbes interact constantly with the intestinal lining and immune system.
A healthy microbiome produces beneficial metabolites, including short-chain fatty acids such as butyrate, which help nourish the intestinal lining, support barrier integrity and regulate inflammatory signalling.
When that ecosystem becomes disrupted, we may see dysbiosis, reduced microbial diversity, lower levels of beneficial butyrate-producing bacteria and increased mucosal immune activity.
And this is where the connection becomes interesting.
Dysbiosis may contribute to inflammation.
Inflammation may increase hepcidin.
Higher hepcidin can reduce iron availability.
At the same time, iron itself influences the microbiome, meaning this relationship runs in both directions.
It is not as simple as saying dysbiosis causes low ferritin. But when ferritin remains stubbornly low despite appropriate iron replacement — particularly in someone who also has bloating, altered bowel habits or other signs of gastrointestinal dysfunction — the gut becomes an important part of the investigation.
There is another twist.
Ferritin is not only a marker of iron stores; it is also an acute-phase protein, meaning inflammation can push ferritin upwards.
So in an inflammatory state, a ferritin result that appears “normal” does not necessarily mean iron availability is optimal.
This is why I like to look at the pattern: ferritin alongside haemoglobin, MCV, transferrin saturation and inflammatory markers such as CRP — and, where appropriate, markers of gastrointestinal inflammation.
Of course, persistent iron deficiency should always prompt us to consider the established causes: inadequate intake, menstrual or gastrointestinal blood loss, coeliac disease and other causes of impaired absorption.
But when those pieces have been considered and the ferritin still refuses to budge, simply adding more iron may not answer the most important question:
Why isn’t the body responding to it?
Sometimes that stubborn ferritin result is asking us to look beyond iron — and towards the relationship between the gut microbiome, inflammation and hepcidin.
Because sometimes the problem isn’t simply the amount of iron coming in.
It’s whether the gates are open to let it through.
Persistent or unexplained iron deficiency should be medically investigated. Microbiome assessment can provide additional context in appropriate cases but should not replace investigation for blood loss, coeliac disease or other gastrointestinal pathology.
Image by magnific